Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
Top Cited Papers
- 1 January 2005
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (1) , 105-110
- https://doi.org/10.1038/modpathol.3800259
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- WT1 is Differentially Expressed in Serous, Endometrioid, Clear Cell, and Mucinous Carcinomas of the Peritoneum, Fallopian Tube, Ovary, and EndometriumInternational Journal of Gynecological Pathology, 2004
- The Immunohistochemical Diagnosis of MesotheliomaThe American Journal of Surgical Pathology, 2003
- Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different TypesThe American Journal of Surgical Pathology, 2003
- WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body FluidsAmerican Journal of Clinical Pathology, 2002
- Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of AngiosarcomasLaboratory Investigation, 2002
- WT1 Immunoreactivity in Uterine Papillary Serous Carcinomas Is Different From Ovarian Serous CarcinomasAmerican Journal of Clinical Pathology, 2002
- Immunohistochemical Analysis Still Has a Limited Role in the Diagnosis of Malignant MesotheliomaAmerican Journal of Clinical Pathology, 2001
- WT1 Is an Integral Component of an Antibody Panel to Distinguish Pancreaticobiliary and Some Ovarian Epithelial NeoplasmsAmerican Journal of Clinical Pathology, 2001
- Anti‐cytokeratin 5/6: a positive marker for epithelioid mesotheliomaHistopathology, 1997
- Calretinin: A Novel Immunocytochemical Marker for MesotheliomaThe American Journal of Surgical Pathology, 1996